In conclusion, we show that the long and short form of TSLP differentially regulate IgA production, which may help explain the mechanisms behind the development and exacerbations of asthma and support the effectiveness of therapeutic interventions targeting aberrant TSLP production. This evidence concerns the gene CD79A and asthma.